Essa Pharma Inc. clarified the Nasdaq due bill trading related to a cash distribution announcement.
The distribution was paid to shareholders on August 22, 2025.
Shareholders received approximately $1.6910318 per Common Share in the distribution.
Cash Distribution Details
Company announced a return of capital distribution amounting to US$80,000,000.
Ex-Dividend Date Correction
The ex-dividend date for the distribution was corrected to August 25, 2025, with the actual due bill period being August 19-22, 2025.
Transaction with XenoTherapeutics
Announcement of a transaction with XenoTherapeutics for the acquisition of all issued Common Shares.
- Essa Pharma's correction of the due bill period ensures transparency and clarity for shareholders.
- The completion of the transaction with XenoTherapeutics signifies a strategic move in the company's business direction.
Essa Pharma Inc.'s proactive communication and transparency regarding the Nasdaq due bill issue reflect its commitment to shareholder interests and regulatory compliance.